Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus
The report examines the optimal use of the PSA test for detecting prostate cancer in asymptomatic UK men, recommends proactive testing for those at higher risk, and suggests reviewing existing guidelines to improve screening practices.
The impact of pre-biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
The article finds that adding pre-biopsy MRI to standard PSA testing improves the detection of significant prostate cancers, reduces diagnoses of less severe cases, and helps many men avoid unnecessary biopsies, though its long-term impact on prostate cancer-specific mortality remains uncertain.
How to improve the quality of your MRI
Prostate Cancer UK is analyzing the PRIME trial and GLIMPSE study’s groundbreaking MRI results to assess their potential impact on men with prostate cancer.
